Topic: biomedical imaging

Supports therapeutically motivated drug-discovery research, including experimentally validated AI methods and biomedical imaging. Pure chemistry without therapeutic evaluation is excluded. The letter-of-intent deadline is 30 October 2026 at noon Eastern time; full applications are by invitation.

Despite the challenges COVID-19 has continued to present, Monash Biomedical Imaging (MBI) has had another outstanding year in terms of publications and scientific output. In this webinar, Professor Gary Egan, Director of MBI, will present an overview of MBI’s achievements during 2021 and outline the biomedical imaging research programs and partnerships in 2022. His presentation will cover: • MBI operational and research achievements during 2021 • Biomedical imaging technology developments and research outcomes during 2021 • Linked laboratories and research teams at MBI • Progress on the develo